Prognostic Value of Ventricular-Arterial Coupling After Transcatheter Aortic Valve Replacement on Midterm Clinical Outcomes
- PMID: 34533038
- PMCID: PMC8649497
- DOI: 10.1161/JAHA.120.019267
Prognostic Value of Ventricular-Arterial Coupling After Transcatheter Aortic Valve Replacement on Midterm Clinical Outcomes
Abstract
Background Ventricular-arterial coupling predicts outcomes in patients with heart failure. The arterial elastance to end-systolic elastance ratio (Ea/Ees) is a noninvasively assessed index that reflects ventricular-arterial coupling. We aimed to determine the prognostic value of ventricular-arterial coupling assessed through Ea/Ees after transcatheter aortic valve replacement to predict clinical events. Methods and Results We retrieved data on 1378 patients (70% women) who underwent transcatheter aortic valve replacement between October 2013 and May 2017 from the OCEAN-TAVI (Optimized transCathEter vAlvular iNtervention) Japanese multicenter registry. We determined the association between Ea/Ees and the composite end point of hospitalization for heart failure and cardiovascular death by classifying the patients into quartiles based on Ea/Ees values (group 1: <0.326; group 2: 0.326-0.453; group 3: 0.453-0.666; and group 4: >0.666) during the midterm follow-up after transcatheter aortic valve replacement. During a median follow-up period of 736 days (interquartile range, 414-956), there were 247 (17.9%) all-cause deaths, 89 (6.5%) cardiovascular deaths, 130 (9.4%) hospitalizations for heart failure, and 199 (14.4%) composite events of hospitalization for heart failure and cardiovascular death. The incidence of the composite end point was significantly higher in group 2 (hazard ratio [HR], 1.76; 95% CI, 1.08-2.87 [P=0.024]), group 3 (HR, 2.43; 95% CI, 1.53-3.86 [P<0.001]), and group 4 (HR, 2.89; 95% CI, 1.83-4.57 [P<0.001]) than that in group 1. On adjusted multivariable Cox analysis, Ea/Ees was significantly associated with composite events (HR, 1.47 per 1-unit increase; 95% CI, 1.08-2.01 [P=0.015]). Conclusions These findings suggest that a higher Ea/Ees at discharge after transcatheter aortic valve replacement is associated with adverse clinical outcomes during midterm follow-up. Registration URL: https://www.upload.umin.ac.jp/. Unique identifier: UMIN000020423.
Keywords: heart failure; transcatheter aortic valve replacement; ventricular‐aortic coupling.
Conflict of interest statement
Dr Saito, Dr Yamamoto, Dr Tada, Dr Naganuma, Dr Shirai, Dr Mizutani, and Dr Watanabe are clinical proctors for Edwards Lifesciences and Medtronic. Dr Araki, Dr Tabata, Dr Takagi, and Dr Hayashida are clinical proctors of Edwards Lifesciences. Dr Ueno is a clinical proctor for Medtronic. The remaining authors have no disclosures to report.
Figures



References
-
- Ramahi TM, Longo MD, Cadariu AR, Rohlfs K, Slade M, Carolan S, Vallejo E, Wackers FJ. Dobutamine‐induced augmentation of left ventricular ejection fraction predicts survival of heart failure patients with severe non‐ischaemic cardiomyopathy. Eur Heart J. 2001;22:849–856. DOI: 10.1053/euhj.2001.2654. - DOI - PubMed
-
- Matsumoto K, Tanaka H, Ooka J, Motoji Y, Sawa T, Mochizuki Y, Ryo K, Tatsumi K, Hirata KI. Significant prognostic impact of improvement in ventriculo‐arterial coupling induced by dobutamine stress on cardiovascular outcome for patients with dilated cardiomyopathy. Eur Heart J Cardiovasc Imaging. 2016;17:1296–1304. DOI: 10.1093/ehjci/jev327. - DOI - PubMed
-
- Obokata M, Kurosawa K, Ishida H, Ito K, Ogawa T, Ando Y, Kurabayashi M, Negishi K. Incremental prognostic value of ventricular‐arterial coupling over ejection fraction in patients with maintenance hemodialysis. J Am Soc Echocardiogr. 2017;30:444–453.e2. DOI: 10.1016/j.echo.2016.12.014. - DOI - PubMed
Publication types
MeSH terms
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Medical